What is the official ID of this bill?

The official print number for this legislation is HR 6674.

When did the legislative process begin?

The process officially started on 2023-12-07.

Where can I read the full text of this legislation?

The full official text is available at: https://www.congress.gov/118/bills/hr6674/BILLS-118hr6674ih.htm

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

Who is the primary sponsor?

The primary sponsor is Rep. Kildee, Daniel T. [D-MI-8].

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Environment, Manufacturing, and Critical Materials.

Analysis and Potential Impact of HR 6674

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

Better Care for PFAS Patients: New Medical Guidelines

Q: What are the main provisions?

Key points include: Regular assessments of PFAS health effects: Experts will study how PFAS substances measured in human tissues impact health. New recommendations for doctors: Based on these studies, up-to-date guidelines will be developed to help doctors treat patients with PFAS-related health issues. Public access to information: Guidelines will be available online and disseminated to health authorities, ensuring everyone can benefit.

This act aims to improve healthcare for individuals affected by PFAS substances, commonly known as "forever chemicals." It will provide citizens with access to up-to-date information and medical recommendations on the health effects of these substances, helping doctors better diagnose and treat patients. The act ensures regular updates to these guidelines, keeping care aligned with the latest scientific knowledge.

Key points

Regular assessments of PFAS health effects: Experts will study how PFAS substances measured in human tissues impact health.

New recommendations for doctors: Based on these studies, up-to-date guidelines will be developed to help doctors treat patients with PFAS-related health issues.

Public access to information: Guidelines will be available online and disseminated to health authorities, ensuring everyone can benefit.

article Official text account_balance Process page notifications_active Track this Bill

gavel

Status:

Expired

Record your position for audit.

Why does your vote on bills matter?

It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.

Additional Information

Better Care for PFAS Patients Act of 2023

Print number: HR 6674

Sponsor: Rep. Kildee, Daniel T. [D-MI-8]

Process start date: 2023-12-07

System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.

Summarized by: gemini-2.5-flash-preview-05-20

Source data: api.congress.gov

AI work logs for this document launch

Better Care for PFAS Patients: New Medical Guidelines

Key Questions about Better Care for PFAS Patients: New Medical Guidelines